Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pulmonx | LUNG | Nov 22, 2024 | 6.79 | +5.76 |
Pulse Biosciences | PLSE | Nov 22, 2024 | 17.68 | +9.68 |
PulteGroup | PHM | Nov 22, 2024 | 129.76 | +1.28 |
Puma Biotechnology | PBYI | Nov 22, 2024 | 3.00 | +3.45 |
Pure Cycle | PCYO | Nov 22, 2024 | 14.03 | +1.67 |
Pure Storage A | PSTG | Nov 22, 2024 | 51.66 | +0.19 |
PureCycle Technologies | PCT | Nov 22, 2024 | 11.93 | +2.05 |
PureCycle Technologies Unit | PCTTU | Nov 22, 2024 | 14.00 | -4.11 |
Purefunds ISE Junior Silver [Sm | SILJ | Nov 22, 2024 | 12.07 | -0.25 |
PureTech Health ADR | PRTC | Nov 22, 2024 | 22.55 | +3.54 |
Purple Biotech ADR | PPBT | Nov 22, 2024 | 2.19 | -13.78 |
Purple Innovation | PRPL | Nov 22, 2024 | 0.88 | +3.97 |
Putnam Managed Municipal Income Trust | PMM | Nov 22, 2024 | 6.16 | -0.48 |
Putnam Master Intermediate Income Trust | PIM | Nov 22, 2024 | 3.23 | -0.15 |
Putnam Municipal Opportunities Trust | PMO | Nov 22, 2024 | 10.36 | -0.38 |
Putnam Premier Income Trust | PPT | Nov 22, 2024 | 3.51 | -0.28 |
PVH | PVH | Nov 22, 2024 | 103.87 | +4.43 |
Pyrophyte Acquisition | PHYT | Nov 22, 2024 | 11.55 | 0.00 |
Pyxis Oncology | PYXS | Nov 22, 2024 | 1.90 | -9.52 |
Pyxis Tankers | PXS | Nov 22, 2024 | 4.08 | +1.49 |
Pyxis Tankers Pref | PXSAP | Nov 22, 2024 | 24.97 | 0.00 |
Q2 | QTWO | Nov 22, 2024 | 106.37 | +1.35 |
Q32 Bio | QTTB | Nov 22, 2024 | 24.55 | -9.21 |
QCR | QCRH | Nov 22, 2024 | 92.67 | +1.90 |
QIAGEN | QGEN | Nov 22, 2024 | 42.78 | +1.06 |
Qifu Technology ADR | QFIN | Nov 22, 2024 | 34.53 | -1.93 |
QMMM | QMMM | Nov 22, 2024 | 0.75 | +28.58 |
Qomolangma Acquisition | QOMO | Nov 22, 2024 | 11.55 | 0.00 |
Qorvo | QRVO | Nov 22, 2024 | 69.25 | +2.03 |
QT Imaging | QTI | Nov 22, 2024 | 0.47 | -8.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.